Glucose-sensitive insulin with attenuation of hypoglycaemia
Nature · 24.10.2024 · 634 (8035) · 944-951
DOI: 10.1038/s41586-024-08042-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 16.10.2024. Verfasst von Thomas Hoeg-Jensen und 31 weiteren Autor:innen. Beteiligte Einrichtung: Global Research Technologies, Novo Nordisk, Bagsværd, Denmark. Hauptthemen laut MEDLINE: Blood Glucose, Glucose, Hypoglycemia, Insulin. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The risk of inducing hypoglycaemia (low blood glucose) constitutes the main challenge associated with insulin therapy for diabetes1,2. Insulin doses must be adjusted to ensure that blood glucose values are within the normal range, but matching insulin doses to fluctuating glucose levels is difficult because even a slightly higher insulin dose than needed can lead to a hypoglycaemic incidence, which can be anything from uncomfortable to life-threatening. It has therefore been a long-standing goal to engineer a glucose-sensitive insulin that can auto-adjust its bioactivity in a reversible manner according to ambient glucose levels to ultimately achieve better glycaemic control while lowering the risk of hypoglycaemia3. Here we report the design and properties of NNC2215, an insulin conjugate with bioactivity that is reversibly responsive to a glucose range relevant for diabetes, as demonstrated in vitro and in vivo. NNC2215 was engineered by conjugating a glucose-binding macrocycle4 and a glucoside to insulin, thereby introducing a switch that can open and close in response to glucose and thereby equilibrate insulin between active and less-active conformations. The insulin receptor affinity for NNC2215 increased 3.2-fold when the glucose concentration was increased from 3 to 20 mM. In animal studies, the glucose-sensitive bioactivity of NNC2215 was demonstrated to lead to protection against hypoglycaemia while partially covering glucose excursions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Global Research Technologies, Novo Nordisk, Bagsværd, Denmark.
- Global Drug Discovery, Novo Nordisk, Bagsværd, Denmark.
- APIGENEX, Prague, Czech Republic.
- University of Bristol, Bristol, UK.
- Carbometrics, Bristol, UK.
- Digital Science and Innovation, Novo Nordisk, Bagsværd, Denmark.
ORCID-Profile: Thomas Hoeg-Jensen, Thomas Kruse, Christian L Brand, Jeppe Sturis, Erica Nishimura, Alice R Madsen, Anthony P Davis, Robert A Tromans, Michael Tomsett, Daniel J Leonard, Eva Johansson, Karen-Margrethe Pedersen, Hanne H F Refsgaard, Lene Alifrangis, Johannes J Fels, Rita Slaaby
Zitieren
APA
Hoeg-Jensen, T., Kruse, T., Brand, C. L., Sturis, J., Fledelius, C., Nielsen, P. K., Nishimura, E., Madsen, A. R., Lykke, L., Halskov, K. S., Koščová, S., Kotek, V., Davis, A. P., Tromans, R. A., Tomsett, M., Peñuelas-Haro, G., Leonard, D. J., Orchard, M. G., Chapman, A., …, & Slaaby, R. (2024). Glucose-sensitive insulin with attenuation of hypoglycaemia. Nature, 634(8035), 944-951. https://doi.org/10.1038/s41586-024-08042-3
Vancouver
Hoeg-Jensen T, Kruse T, Brand CL, Sturis J, Fledelius C, Nielsen PK, et al. Glucose-sensitive insulin with attenuation of hypoglycaemia. Nature. 2024;634(8035):944-951. doi:10.1038/s41586-024-08042-3
BibTeX
@article{HoegJensen2024,
author = {Hoeg-Jensen, Thomas and Kruse, Thomas and Brand, Christian L and Sturis, Jeppe and Fledelius, Christian and Nielsen, Peter K and Nishimura, Erica and Madsen, Alice R and Lykke, Lennart and Halskov, Kim S and Koščová, Simona and Kotek, Vladislav and Davis, Anthony P and Tromans, Robert A and Tomsett, Michael and Peñuelas-Haro, Guillem and Leonard, Daniel J and Orchard, Michael G and Chapman, Andy and Invernizzi, Gaetano and Johansson, Eva and Granata, Daniele and Hansen, Bo F and Pedersen, Thomas A and Kildegaard, Jonas and Pedersen, Karen-Margrethe and Refsgaard, Hanne H F and Alifrangis, Lene and Fels, Johannes J and Neutzsky-Wulff, Anita V and Sauerberg, Per and Slaaby, Rita},
title = {Glucose-sensitive insulin with attenuation of hypoglycaemia},
journal = {Nature},
year = {2024},
volume = {634},
number = {8035},
pages = {944--951},
doi = {10.1038/s41586-024-08042-3}
}
EUVIMED